Prévisions du marché européen du fractionnement du plasma jusqu’en 2028 – Impact du COVID-19 et analyse régionale par produit (immunoglobuline, albumine, concentrés de facteurs de coagulation, inhibiteurs de protéase et autres produits plasmatiques), application (neurologie, immunologie, hématologie, soins intensifs, pneumologie et autres Applications) et utilisateur final (hôpitaux et cliniques, laboratoires de recherche clinique et instituts universitaires)
Introduction au marché
Le marché européen du fractionnement du plasma comprend les marchés consolidés de l\'Allemagne, de la France, Royaume-Uni, Espagne, Italie et reste de l’Europe. L’Europe occupe une position importante sur le marché mondial du fractionnement du plasma et devrait enregistrer un taux de croissance robuste au cours de la période de prévision. La croissance du marché dans la région devrait être due au vieillissement de la population, à l\'utilisation croissante d\'immunoglobulines pour traiter diverses maladies chroniques, à la prévalence croissante des troubles immunitaires et hémorragiques et à l\'essor des thérapies plasmatiques pour la gestion des maladies. Tous devraient stimuler la croissance du marché pour la région Europe au cours de la période. période de prévision.
Dans les pays européens, la pratique médicale de diverses maladies chroniques telles que les troubles neurologiques, les troubles hématologiques et les maladies respiratoires a changé. En raison de la diversification du personnel médical et de la décision de se concentrer sur le traitement des personnes gravement malades, l’augmentation du nombre de cas de COVID-19 a eu un impact sur la détection et le traitement des maladies. En raison de la pandémie actuelle, de nombreux organismes de recherche se concentrent davantage sur les études sur le COVID-19 et travaillent dur pour mieux comprendre le virus. Certaines agences fédérales de la région ont pris l’initiative d’adopter la thérapie plasmatique pour traiter les patients atteints du COVID-19. Par exemple, l’Agence nationale de sécurité du médicament et des produits de santé (ANSM) a annoncé que l’immunothérapie par plasma serait utilisée pour traiter les patients gravement malades. En outre, la Commission européenne a recommandé le recours d’urgence à la thérapie plasmatique de convalescence pour traiter les patients critiques. Ainsi, l’utilisation de thérapies plasmatiques dans la gestion du COVID-19 a eu un impact positif sur le marché dans une certaine mesure. Cependant, en raison du COVID-19, la pratique médicale globale des troubles neurologiques, des troubles hématologiques et des troubles idiosyncrasiques a changé, et la majorité des sociétés pharmaceutiques et biopharmaceutiques mettent l\'accent sur le développement de nouveaux traitements pour le COVID-19, ce qui a un impact négatif sur la santé. la croissance du marché.
< p>Aperçu et dynamique du marchéLe marché du fractionnement du plasma en Europe devrait passer de 6 824,67 millions de dollars US en 2021 à 10 402,95 millions de dollars US d’ici 2028 ; on estime qu\'il augmentera à un TCAC de 6,2 % de 2021 à 2028. Augmentation de la population gériatrique, utilisation croissante des immunoglobulines dans divers domaines thérapeutiques tels que la neurologie, l\'hématologie, les maladies génétiques rares et les maladies auto-immunes, ainsi qu\'une demande croissante de thérapies dérivées du plasma pour la gestion. de maladies devraient toutes stimuler le marché du fractionnement du plasma dans le reste de l’Europe. En outre, diverses entreprises en Europe investissent davantage dans des activités de recherche et développement pour développer et lancer de nouvelles approches de thérapies plasmatiques pour la gestion des maladies.
Segments clés du marché
Le marché européen du fractionnement du plasma est segmenté en produit, application, utilisateur final et pays. Le marché européen du fractionnement du plasma, en fonction du produit, a été segmenté en immunoglobuline, albumine, concentrés de facteurs de coagulation, inhibiteurs de protéase et autres. Le segment des immunoglobulines est susceptible de détenir la plus grande part du marché en 2021. Le marché européen du fractionnement du plasma, en fonction des applications, est segmenté en neurologie, immunologie, hématologie, soins intensifs, pneumologie et autres. En 2021, le segment Neurologie devrait détenir la plus grande part du marché. Le marché européen du fractionnement du plasma, basé sur l’utilisateur final, est segmenté en hôpitaux et cliniques, laboratoires de recherche clinique et instituts universitaires. En 2021, le segment des hôpitaux et cliniques devrait détenir la plus grande part du marché. En fonction des pays, le marché européen du fractionnement du plasma est segmenté en France, Allemagne, Italie, Espagne, Royaume-Uni et reste de l’Europe. Le reste de l\'Europe détenait la plus grande part de marché en 2021.
Principales sources et sociétés répertoriées
Quelques sources primaires et secondaires majeures mentionnées pour la préparation de ce rapport sur le marché du fractionnement du plasma en Europe sont les sites Web des entreprises, les rapports annuels, les rapports financiers, les documents gouvernementaux nationaux et les bases de données statistiques, entre autres. Les principales sociétés répertoriées dans le rapport sont Bharat Serums and Vaccines Limited (BSV) ; Laboratoire de produits biologiques Ltd.; Biotest SA; CSL Limitée ; Grifols, SA ; Kédrion SpA ; Octapharma AG; Sanquín ; et SK Plasma.
Rapport sur les raisons d\'acheter
- Comprendre le paysage du marché européen du fractionnement du plasma et identifier les segments de marché les plus susceptibles de garantir un fort retour.
- Gardez une longueur d\'avance en comprenant le paysage concurrentiel en constante évolution du marché européen du fractionnement du plasma.
- Planifiez efficacement les fusions et acquisitions et les accords de partenariat sur le marché européen du fractionnement du plasma en identifiant les segments de marché présentant les ventes probables les plus prometteuses.
- Aide à prendre des décisions commerciales éclairées à partir d\'une analyse perspicace et complète des Performances du marché de divers segments du marché européen du fractionnement du plasma.
- Obtenez les prévisions de revenus du marché pour le marché par divers segments de 2021 à 2028 dans la région Europe.
Europe Marché du fractionnement du plasma Segmentation
Marché européen du fractionnement du plasma - Par produit
- Immunoglobuline
- Immunoglobuline intraveineuse (IVIG)
- Immunoglobuline sous-cutanée (SCIG)
- Alalbumine
- Concentrés de facteurs de coagulation
- Inhibiteurs de protéase
- Autres
Marché européen du fractionnement du plasma - Par Application
- Neurologie
- Immunologie
- Hématologie
- Soins intensifs
- Pneumologie
- Autres
Marché européen du fractionnement du plasma - Par utilisateur final
- Hôpitaux et cliniques
- Laboratoires de recherche clinique
- Instituts universitaires
Marché européen du fractionnement du plasma - Par pays
- France
- Allemagne
- Italie
- Espagne
- Royaume-Uni
- Reste de l\'Europe
Marché européen du fractionnement du plasma - Profils des entreprises
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limitée
- Grifols, SA
- Kedrion SpA
- Octapharma AG
- Sanquin
- SK Plasma
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Plasma Fractionation Market – By Product
1.3.2 Europe Plasma Fractionation Market – By Application
1.3.3 Europe Plasma Fractionation Market – By End User
1.3.4 Europe Plasma Fractionation Market – By Country
2. Europe Plasma Fractionation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Plasma Fractionation Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Plasma Fractionation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Plasma Therapy Being Widely Used
5.1.2 Market is Developing Due to Active Participation of the Key Players
5.2 Market Restraints
5.2.1 Alternate Non-Plasma Substitutes Available
5.3 Future Trends
5.3.1 Novel Diseases Getting Treated By Using Plasma Therapy
5.4 Impact Analysis
6. Plasma Fractionation Market – Europe Analysis
6.1 Europe Plasma Fractionation Market Revenue Forecast and Analysis
7. Europe Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 Europe Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3 Immunoglobulin
7.3.1 Overview
7.3.2 Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.1 Intravenous Immunoglobulin (IVIG)
7.3.2.1.1 Overview
7.3.2.1.2 Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1 Overview
7.3.2.2.2 Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Albumin
7.4.1 Overview
7.4.2 Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Coagulation Factor Concentrates
7.5.1 Overview
7.5.2 Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Protease Inhibitors
7.6.1 Overview
7.6.2 Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Other Plasma Products
7.7.1 Overview
7.7.2 Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
8. Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3 Neurology
8.3.1 Overview
8.3.2 Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Immunology
8.4.1 Overview
8.4.2 Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Hematology
8.5.1 Overview
8.5.2 Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Critical Care
8.6.1 Overview
8.6.2 Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Pulmonology
8.7.1 Overview
8.7.2 Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Clinical Research Laboratories
9.4.1 Overview
9.4.2 Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic Institutes
9.5.1 Overview
9.5.2 Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10. Europe Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Plasma Fractionation Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3.1 Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5 Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3.1 France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5 France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3.1 UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3.1 Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.4 Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5 Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3.1 Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.4 Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5 Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3.1 Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.4 Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5 Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Europe Plasma Fractionation Market
11.1 Europe: Impact Assessment Of COVID-19 Pandemic
12. Plasma Fractionation Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Followed by Major Market Players (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Biotest AG.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Octapharma AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Kedrion S.p.A
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 CSL Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Grifols, S.A.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio Products Laboratory Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sanquin
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bharat Serums and Vaccines Limited (BSV)
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 SK Plasma
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 7. France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 11. UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic developments done by Companies
Table 27. Glossary of Terms, Plasma Fractionation Market
LIST OF FIGURES
Figure 1. Europe Plasma Fractionation Market Segmentation
Figure 2. Europe Plasma Fractionation Market Segmentation, By Country
Figure 3. Europe Plasma Fractionation Market Overview
Figure 4. Immunoglobulin Segment Held the Largest Share of the Product Segment in Europe Plasma Fractionation Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe and PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to Europe Plasma Fractionation Market
Figure 8. Europe Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. Europe Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 10. Europe Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Europe Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Europe Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 16. Europe Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 18. Europe Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. Europe Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. Europe Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. Europe Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22. Europe Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. Europe Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 25. Europe Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. Europe Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. Europe Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. Europe: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 30. Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 34. Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36. Impact of COVID-19 Pandemic in European Country Markets
Figure 37. Growth Strategies Followed by Major Market Players (%)- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- Sanquin
- SK Plasma
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe plasma fractionation market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution